Are ketogenic diets promising for Alzheimer's disease? A translational review

被引:47
|
作者
Lilamand, Matthieu [1 ,2 ,3 ,4 ]
Porte, Baptiste [1 ,2 ]
Cognat, Emmanuel [1 ,2 ]
Hugon, Jacques [1 ,2 ]
Mouton-Liger, Francois [1 ,2 ]
Paquet, Claire [1 ,2 ]
机构
[1] Univ Paris, INSERM, U1144, Optimisat Therapeut Neuropsychopharmacol, Paris, France
[2] Nord Univ Paris, Lariboisiere Hosp, APHP, CMRR Paris Nord Ile France,Ctr Neurol Cognit, 200 Rue Faubourg, F-75010 Paris, France
[3] APHP Nord Univ Paris, Dept Geriatr, Bichat, Bretonneau Hospitals, F-75018 Paris, France
[4] Nord Univ Paris, Bichat & Bretonneau Hosp, APHP, Dept Geriatr, F-75018 Paris, France
关键词
Ketogenic diet; Alzheimer's disease; Brain metabolism; Animal models; MOUSE MODEL; COGNITIVE IMPAIRMENT; BETA-HYDROXYBUTYRATE; KETONE ESTER; SUPPLEMENTATION; METABOLISM; MITOCHONDRIA; MEMORY;
D O I
10.1186/s13195-020-00615-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Brain amyloid deposition and neurofibrillary tangles in Alzheimer's disease (AD) are associated with complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolism is closely related to neuroinflammation. Ketogenic diets (KDs) include a high amount of fat, low carbohydrate and medium-chain triglyceride (MCT) intake. KDs lead to the production of ketone bodies to fuel the brain, in the absence of glucose. These nutritional interventions are validated treatments of pharmacoresistant epilepsy, consequently leading to a better intellectual development in epileptic children. In neurodegenerative diseases and cognitive decline, potential benefits of KD were previously pointed out, but the published evidence remains scarce. The main objective of this review was to critically examine the evidence regarding KD or MCT intake effects both in AD and ageing animal models and in humans. Main body We conducted a review based on a systematic search of interventional trials published from January 2000 to March 2019 found on MEDLINE and Cochrane databases. Overall, 11 animal and 11 human studies were included in the present review. In preclinical studies, this review revealed an improvement of cognition and motor function in AD mouse model and ageing animals. However, the KD and ketone supplementation were also associated with significant weight loss. In human studies, most of the published articles showed a significant improvement of cognitive outcomes (global cognition, memory and executive functions) with ketone supplementation or KD, regardless of the severity of cognitive impairments previously detected. Both interventions seemed acceptable and efficient to achieve ketosis. Conclusion The KD or MCT intake might be promising ways to alter cognitive symptoms in AD, especially at the prodromal stage of the disease. The need for efficient disease-modifying strategies suggests to pursue further KD interventional studies to assess the efficacy, the adherence to this diet and the potential adverse effects of these nutritional approaches.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Are ketogenic diets promising for Alzheimer’s disease? A translational review
    Matthieu Lilamand
    Baptiste Porte
    Emmanuel Cognat
    Jacques Hugon
    François Mouton-Liger
    Claire Paquet
    Alzheimer's Research & Therapy, 12
  • [2] Ketogenic diets and Alzheimer's disease
    Lange, Klaus W.
    Lange, Katharina M.
    Makulska-Gertruda, Ewelina
    Nakamura, Yukiko
    Reissmann, Andreas
    Kanaya, Shigehiko
    Hauser, Joachim
    FOOD SCIENCE AND HUMAN WELLNESS, 2017, 6 (01) : 1 - 9
  • [3] Ketogenic diets and Alzheimer's disease
    Klaus W.Lange
    Katharina M.Lange
    Ewelina Makulska-Gertruda
    Yukiko Nakamura
    Andreas Reissmann
    Shigehiko Kanaya
    Joachim Hauser
    Food Science and Human Wellness, 2017, 6 (01) : 1 - 9
  • [4] Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review
    Lilamand, Matthieu
    Mouton-Liger, Francois
    Di Valentin, Emmanuelle
    Sanchez Ortiz, Marta
    Paquet, Claire
    FRONTIERS IN NUTRITION, 2022, 8
  • [5] Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
    Wlodarek, Dariusz
    NUTRIENTS, 2019, 11 (01):
  • [6] Ketogenic diet therapy in Alzheimer's disease: an updated review
    Lilamand, Matthieu
    Mouton-Liger, Francois
    Paquet, Claire
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2021, 24 (04): : 372 - 378
  • [7] The role of adiponectin in Alzheimer's disease: A translational review
    Sindzingre, Louise
    Bouaziz-Amar, Elodie
    Mouton-Liger, Francois
    Cognat, Emmanuel
    Dumurgier, Julien
    Vrillon, Agathe
    Paquet, Claire
    Lilamand, Matthieu
    JOURNAL OF NUTRITION HEALTH & AGING, 2024, 28 (03):
  • [8] The Ketogenic Diet and Alzheimer's Disease
    Hersant, H.
    Grossberg, G.
    JOURNAL OF NUTRITION HEALTH & AGING, 2022, 26 (06): : 606 - 614
  • [9] Ketogenic Diet in Alzheimer's Disease
    Rusek, Marta
    Pluta, Ryszard
    Ulamek-Koziol, Marzena
    Czuczwar, Stanislaw J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (16)
  • [10] The Ketogenic Diet and Alzheimer’s Disease
    Haley Hersant
    G. Grossberg
    The journal of nutrition, health & aging, 2022, 26 : 606 - 614